Author

A. Adibekian

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Assay:proteomics· 2 Organism:human· 1 Organism:plant (other)· 1

Frequent Co-Authors

D. Abegg· 3 shared F. F. Faucher· 2 shared M. Bogyo· 2 shared S. Lovell· 2 shared D. A. Fidock· 1 shared E. Yeh· 1 shared F. Hackett· 1 shared H. S. Haniff· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiochemistry

D. Abegg

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Mixed Alkyl/Aryl Phosphonates Identify Metabolic Serine Hydrolases as Antimalarial Targets

J. M. Bennett, S. K. Narwal, S. Kabeche, D. Abegg, F. Hackett, T. Yeo, V. Li, R. K. Muir, F. F. Faucher, S. Lovell, M. Blackman, A. Adibekian, E. Yeh, D. A. Fidock, M. Bogyo

The paper identifies mixed alkyl/aryl phosphonates as anti-malarial compounds that inhibit serine hydrolases with low resistance potential.

Cell Chemical Biology · Sep 1, 2024Peer-reviewedMicrobiology

Solid Phase Synthesis of Fluorosulfate Containing Macrocycles for Chemoproteomic Workflows

F. F. Faucher, D. Abegg, P. Ipock, A. Adibekian, S. Lovell, M. Bogyo

The paper describes a solid-phase synthesis method for creating macrocyclic peptides with fluorosulfate electrophiles, enabling chemoproteomic screening and target identification.

bioRxiv · Feb 17, 2023Biochemistry

Small molecules exploiting structural differences within microRNA-200 precursors family members reverse a type 2 diabetes phenotype

H. S. Haniff, X. Liu, L. Knerr, M. Lemurell, D. Abegg, A. Adibekian, M. D. Disney

The paper designs small molecules that target the structural differences in miR-200 precursor family members to selectively reverse a type 2 diabetes phenotype.

bioRxiv · Jun 27, 2020 · PreprintBiochemistry